Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. - Wikidata - awgldk - TriplyDB

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

http://www.wikidata.org/entity/Q34524019

about

Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults Preliminary data on the use of apheresis in inflammatory bowel disease.Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.Developments in the apheresis procedure for the treatment of inflammatory bowel disease.The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis Neutrophil-dependent oxidative stress in ulcerative colitis The immune response in inflammatory bowel disease.Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.Therapeutic strategies for the management of ulcerative colitis.Granulocytapheresis in the treatment of patients with active ulcerative colitis.Case of severe alcoholic hepatitis treated with granulocytapheresis.Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats.The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Review article: the role of non-biological drugs in refractory inflammatory bowel disease.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.Granulocyte and monocyte adsorptive apheresis for patients with chronic hepatitis C virus infection: a report on six cases with high plasma viremia.Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.Leukocyte apheresis in the management of ulcerative colitis.Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C.Effects of preoperative leukocytapheresis on inflammatory cytokines following surgery for ulcerative colitis: a prospective randomized study.Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy.Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis.Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis.Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.Granulocyte adsorptive apheresis for leg ulcers complicated by rheumatoid arthritis: a report on three successfully treated cases.First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study.Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.

P2860

Q26768280-CEE0AF65-3E9A-4175-991E-5A467CD667E4 Q31027618-72929DF3-AFAF-4EAE-B7D1-775E32B4DAA2 Q33626027-61AEC32A-46FF-438A-B143-117A29A78C53 Q33867970-7A5E299C-1661-43E8-8B45-1FA49105D03A Q34870365-7CD6E5EF-EC39-49F4-8C96-58069CA13FCD Q34958550-2AA179A9-F8D5-418D-928A-580CFF1AF5AA Q35010974-0DB98554-ECF3-4D78-A5AF-F454DD0A6734 Q35200770-3BC7FFD7-8DBF-46A6-AA49-9221591D029C Q36210314-CA87DAAC-1B24-4DF2-93B9-52B7AA59DD76 Q36353616-83FB8470-C137-4132-9767-1E1D7A5CE326 Q36446929-FD51D0CE-EA1D-4AC0-8FE1-2166B69A3963 Q36474506-7BB1CE3B-0168-4858-80D3-998468451321 Q36508776-3265121E-AAF3-4BEE-A4BC-DC1D38D49898 Q36846736-BE29F000-681B-4280-8B26-53C27EEAF2FA Q37125624-EF2C730D-1092-4900-932F-5281A28E2A18 Q37318035-93B2C852-6D01-4D98-937D-349627D8AD66 Q37345830-DEDA8D5E-5C52-4541-8C5C-516B4B2FDBD6 Q37418907-F9173D9E-5831-4F13-B455-258B5C907558 Q37721753-D5FB607E-CB27-4462-9B68-85A3AD79F2A7 Q37809574-A81B33BF-338B-4578-A1B8-5F41A90800E7 Q37817487-A45A1E74-E3CF-4870-B4F8-0E4A12EB3D1E Q37993226-98F14010-09C7-489C-BAA8-2126222B4CBD Q39255696-9FDC4612-F4D1-4666-95D0-915FB18C39A9 Q40525197-20955343-51BA-4AD3-9469-017C2B0F43DB Q40525397-20244330-8026-45EE-87C7-F77099066078 Q41992829-4318C675-3F70-4540-8B0D-9507F519302F Q42704574-5BB310C3-E1D3-4A2F-91DF-5076BEDDCEB5 Q42726307-A9FDEE6A-65CC-468D-8640-6C2D2AC3488A Q42991664-417A6B9C-C030-4C03-B901-C9FDB23F51BB Q43411685-7707C690-397E-450E-82B9-8EBC40361A74 Q43467932-E277A599-6585-4FB9-9C34-C2EEA57CE585 Q43963773-6EA570F2-2D95-4F27-B9F4-E4117BAC1FA2 Q44552976-7F7C9449-B35F-45ED-8F40-BDE7AA610DD7 Q44904210-FA2D236D-4D4D-452F-8DA2-6CFC3E3428B2 Q45009367-D194A36F-6808-4946-8134-AB729C0433EB Q45107349-FCA27CE9-E0DA-4A83-AB87-999645EB0EF2 Q45114690-2CB42238-4C1E-4B1F-A67B-D826CF5D43B6 Q45192021-502DD8FF-DA5E-4C7B-ACDB-C4B4050184B7 Q46070937-7DBB7B07-5CD5-4F2B-BEC7-0C205779AF02 Q46303987-53C297E3-E2F7-43AC-A9F2-E427D1521076

P2860

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

http://www.wikidata.org/entity/Q34524019

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@ast

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@en

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@nl

type

label

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@ast

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@en

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@nl

prefLabel

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@ast

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@en

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@nl

P1433

Q34524019-E72B6A64-33B6-4846-B896-B932402F913C

P1476

Q34524019-20E0964B-A945-48B3-A12C-A960FC532E92

P2093

Q34524019-0FE46D23-C6B1-4007-AECC-D112CB1265FA

Q34524019-38A25787-232C-410A-830E-88B8F97BC97E

Q34524019-43462564-804A-4A4D-B621-C08D6BC13664

Q34524019-799A1D1F-E098-45F3-B4DA-CC8E186E38BD

Q34524019-88CE098C-F220-49A5-92D2-3372A2F97168

Q34524019-909ADE34-93B0-4BD6-8ADF-FB9EC153F274

Q34524019-AE728A40-1E50-42BE-8677-1350149EB5A0

Q34524019-FAF93412-6C4B-433B-8BDA-6A42F77B3C24

P2888

Q34524019-23E46BDE-68DF-448B-9DEB-7ED6A68C67B8

P304

Q34524019-12872D5F-9455-4637-A1FE-D4B3C5C5400B

P31

Q34524019-46539933-15E9-47DE-9639-0E667E973165

P356

Q34524019-AC411D25-5599-4B0F-AB00-03FFB1DA2F3B

P433

Q34524019-AC23B61A-177D-43D8-97FE-EB72D4A7A216

P478

Q34524019-B3466EE2-459B-4F1E-B9A8-A31BFA6C6983

P577

Q34524019-BCA2190E-B72D-45AD-AA24-6E19A19C4C58

P6179

Q34524019-E181329F-DADD-41F1-B49F-B78C7915EA44

P698

Q34524019-326BEA5B-8D1B-4EA7-AD6E-73F5B433FF28

P921

Q34524019-93B75CF5-434D-4837-A3BC-588502E2D304

P356

A:1015330816364

P1433

Digestive Diseases and Sciences

P1476

Immunomodulatory effects of gr ...... ients with ulcerative colitis.

@en

P2093

Abby R Saniabadi

http://www.w3.org/2001/XMLSchema#string

Hirobumi Koiwai

http://www.w3.org/2001/XMLSchema#string

Hironori Yamamoto

http://www.w3.org/2001/XMLSchema#string

Kazuhito Sugimura

http://www.w3.org/2001/XMLSchema#string

Masakazu Adachi

http://www.w3.org/2001/XMLSchema#string

Nobuhito Kashiwagi

http://www.w3.org/2001/XMLSchema#string

Takashi Shimoyama

http://www.w3.org/2001/XMLSchema#string

Toshikazu Yoshikawa

http://www.w3.org/2001/XMLSchema#string

P2888

a:1015330816364

P304

1334-1341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1015330816364

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015100588

http://www.w3.org/2001/XMLSchema#string

P698

12064810

http://www.w3.org/2001/XMLSchema#string

P921